Evaluation of TRANSKRIP ® Plus Chemotherapy in Recurrent-Persistent Cervical Cancer
Condition: Cervical CancerInterventions: Drug: Hydralazine/Magnesium; Drug: Placebo; Drug: Carboplatin; Drug: PaclitaxelSponsors: National Institute of Cancerología; Psicofarma S.A. de C.V.Not yet recruiting - verified May 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 20, 2015 Category: Research Source Type: clinical trials
Nitrates In Combination With Hydralazine in cardiorEnal Syndrome (NICHE) Study
Condition: Cardio-Renal SyndromeInterventions: Drug: Hydralazine; Drug: Isosorbide DinitrateSponsors: National University Hospital, Singapore; Singapore Clinical Research Institute; Changi General Hospital; National Heart Centre of Singapore Pte LtdRecruiting - verified January 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 15, 2015 Category: Research Source Type: clinical trials
The Intracerebral Hemorrhage Acutely Decreasing Arterial Pressure Trial II
Condition: Intracerebral HemorrhageIntervention: Drug: labetalol/hydralazine/enalaprilSponsor: University of AlbertaRecruiting - verified October 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 29, 2014 Category: Research Source Type: clinical trials
Safety and Cardiovascular Efficacy of Hydralazine and Isosorbide Dinitrate in Dialysis-Dependent ESRD
Condition: Chronic Hemodialysis (ESRD)Interventions: Drug: Hydralazine/Isorsorbide Dinitrate; Drug: Amlodipine and PlaceboSponsor: Brigham and Women's HospitalNot yet recruiting - verified August 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 26, 2014 Category: Research Source Type: clinical trials
